What is he best known for?
The fields of study he is best known for:
His main research concerns Cell biology, Biochemistry, Cell culture, Oxidative stress and Amyloid beta.
His Cell biology study focuses on Intracellular in particular.
The various areas that he examines in his Biochemistry study include Toxicity and Amyloid precursor protein.
His research in Cell culture intersects with topics in Endocrinology, Cellular differentiation, Nerve growth factor, Molecular biology and Internal medicine.
His study looks at the relationship between Oxidative stress and fields such as Neuroprotection, as well as how they intersect with chemical problems.
The concepts of his Amyloid beta study are interwoven with issues in P3 peptide, Amyloid and Protein precursor.
His most cited work include:
- Hydrogen peroxide mediates amyloid beta protein toxicity. (1904 citations)
- 3D structure of Alzheimer's amyloid-β(1–42) fibrils (1528 citations)
- Generation of reactive oxygen species by the mitochondrial electron transport chain (946 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Cell biology, Biochemistry, Cell culture, Molecular biology and Amyloid.
His work carried out in the field of Cell biology brings together such families of science as Endocrinology, Neurite, Cell adhesion and Programmed cell death.
He works mostly in the field of Biochemistry, limiting it down to topics relating to Toxicity and, in certain cases, Pharmacology, as a part of the same area of interest.
His research on Cell culture also deals with topics like
- Cell that intertwine with fields like Neuroblastoma,
- Cell division together with Tissue culture.
His biological study spans a wide range of topics, including Antibody and Transfection.
The study incorporates disciplines such as Alzheimer's disease and Peptide in addition to Amyloid.
He most often published in these fields:
- Cell biology (38.71%)
- Biochemistry (31.45%)
- Cell culture (25.81%)
What were the highlights of his more recent work (between 2009-2021)?
- Neuroprotection (8.06%)
- Pharmacology (9.27%)
- Neuroscience (9.27%)
In recent papers he was focusing on the following fields of study:
David Schubert mainly focuses on Neuroprotection, Pharmacology, Neuroscience, Disease and Drug discovery.
His Neuroprotection research is multidisciplinary, relying on both Embryonic stem cell, Biochemistry, Mitochondrion, Stem cell and Neurogenesis.
In his works, he undertakes multidisciplinary study on Biochemistry and Hydrazide.
David Schubert has researched Stem cell in several fields, including Glutamate receptor and Cell culture.
His Pharmacology research is multidisciplinary, incorporating elements of Stroke, Glutathione, Neurotrophin and Amyloid.
His study in the field of Sequestosome-1 Protein also crosses realms of Aggrephagy.
Between 2009 and 2021, his most popular works were:
- p62, Ref(2)P and ubiquitinated proteins are conserved markers of neuronal aging, aggregate formation and progressive autophagic defects. (134 citations)
- Fisetin lowers methylglyoxal dependent protein glycation and limits the complications of diabetes (111 citations)
- Modulation of p25 and inflammatory pathways by fisetin maintains cognitive function in Alzheimer's disease transgenic mice (100 citations)
In his most recent research, the most cited papers focused on:
The scientist’s investigation covers issues in Neuroscience, Neurodegeneration, Cell biology, Protein aggregation and Neuroprotection.
David Schubert combines subjects such as Alzheimer's disease, Curcumin, Brain-derived neurotrophic factor and Nerve growth factor with his study of Neuroscience.
David Schubert focuses mostly in the field of Neurodegeneration, narrowing it down to matters related to Aging brain and, in some cases, Phenotypic screening and Intracellular.
His Cell biology study integrates concerns from other disciplines, such as Neural degeneration and Ubiquitin.
His Cooperativity study contributes to a more complete understanding of Biochemistry.
He undertakes multidisciplinary studies into Biochemistry and Amyloid disease in his work.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
